Trial intelligence / Profile preview

Pectoral Nerve Block for Analgesia in Mastectomy

NCT01943240Phase 4Withdrawn

Start
Mar 2014
Primary completion
Mar 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Ropivacaine Pectoral Block with Placebo Pectoral Block (2 arms). Primary endpoint: Total opioid consumption in post anesthesia care unit (PACU) up to 8 hours. Planned start Mar 2014; status: withdrawn.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01943240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01943240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call